Home » Sandoz Gains Dermatology Lead With Fougera
Sandoz Gains Dermatology Lead With Fougera
Novartis’s generic drugs division Sandoz has agreed to buy Fougera Pharmaceuticals for $1.53 billion in cash in a deal that creates the world’s biggest generics company focused on dermatology medicines.
Financial Times
Financial Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May